MTOR and prostate carcinoma: A balance between the activity of the Akt/mTOR and the MAPK/Mnk1 pathway was reported in Prostate cancer cells, where suppression of one pathway was correlated with the activation of another, resulting in a defined translational level of specific mRNAs that supported cancer cell proliferation [64].